Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh Medical Dialogues Bureau8 Nov 2019 4:00 AM GMT"We have found that the appellant in... Jubilant Life Sciences would be liable for a penalty only on one count i.e. for non-disclosure of the China...
New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble Medical Dialogues Bureau7 Nov 2019 10:50 AM GMTCadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China Medical Dialogues Bureau6 Nov 2019 7:56 AM GMTMumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 5:02 AM GMTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
Biocon gets EIR from USFDA for Bengaluru biologics unit Medical Dialogues Bureau6 Nov 2019 3:49 AM GMTNew Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system Medical Dialogues Bureau5 Nov 2019 7:35 AM GMTThe U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a...
Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility Medical Dialogues Bureau5 Nov 2019 7:27 AM GMTNew Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr Medical Dialogues Bureau5 Nov 2019 7:25 AM GMTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA Medical Dialogues Bureau4 Nov 2019 11:01 AM GMTNew Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
GSK Benlysta gets European nod for treatment of children with lupus Medical Dialogues Bureau4 Nov 2019 3:45 AM GMTNew Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
AbbVie says multiple parties vying for assets related to Allergan deal approval Medical Dialogues Bureau4 Nov 2019 3:30 AM GMTAbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office Medical Dialogues Bureau3 Nov 2019 4:25 AM GMT"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...